The Children's Vaccine Initiative: Achieving the Vision (1993)

Chapter: Appendix H: Historical Record of Vaccine Product License Holders in the United States

Previous Chapter: Appendix G: Immunization Schedules
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

H
Historical Record of Vaccine Product License Holders in the United States

TABLE H-1 Vaccine Product License Holders in the United States

Company and Vaccine or Product

Date of License

Date of Revocation

Bionetics Research Inc.a

 

 

BCG vaccine

05/29/1987

06/21/1989

Connaught Laboratories, Inc.b

 

 

BCG live

05/21/1990

 

BCG vaccine

03/31/1967

05/21/1990

Diphtheria & tetanus toxoids & acellular pertussis vaccine, adsorbed

09/20/1992

 

Diphtheria & tetanus toxoids & pertussis vaccine (DTP)

01/03/1978

11/29/1982

Diphtheria & tetanus toxoids, & pertussis vaccine, adsorbed

01/03/1978

 

Diphtheria & tetanus toxoids adsorbed

09/18/1984

 

Diphtheria toxoid

01/03/1978

 

Haemophilus influenzae type b Conjugate

 

 

(diphtheria toxoid conjugate)

12/22/1987

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Haemophilus influenzae type b polysaccharide

12/20/1985

 

Influenza

01/03/1978

 

Meningococcal polysaccharide group A

01/03/1978

 

Meningococcal polysaccharide group C

01/03/1978

 

Meningococcal polysaccharide vaccine, groups A and C combined

01/03/1978

 

Meningococcal polysaccharide vaccine, groups A, C, Y, W135 combined

11/23/1981

 

Pertussis vaccine

01/03/1978

 

Poliomyelitis virus, inactivated human diploid cell

11/20/1987

 

Poliomyelitis virus, inactivated monkey kidney cell

01/24/1963

 

Rabies vaccine

12/27/1991

 

Smallpox vaccine

01/03/1978

 

Tetanus toxoid

01/03/1978

 

Tetanus toxoid, adsorbed

01/03/1978

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

01/03/1978

 

Yellow fever

01/03/1978

 

Connaught Laboratories, Limitedb

 

 

Diphtheria toxoid

04/28/1928

05/27/1977

Tetanus toxoid

01/14/1943

 

Small pox vaccine

10/23/1967

04/01/1980

Dow Chemical Companya

 

 

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

09/11/1970

06/07/1977

Diphtheria toxoid

09/18/1934

06/07/1977

DT, adsorbed

09/11/1970

06/07/1977

DP, adsorbed

09/11/1970

06/07/1977

Measles, live

02/05/1965

06/07/1978

Measles and rubella, live

04/17/1974

06/21/1978

Measles, mumps, rubella, live

04/17/1974

06/21/1978

Mumps virus vaccine, live

04/17/1974

06/21/1978

Pertussis vaccine

10/01/1932

06/07/1977

Rubella virus, live

03/01/1974

06/21/1978

Tetanus toxoid

08/01/1936

06/07/1977

Tetanus toxoid, adsorbed

09/01/1970

06/07/1977

Eli Lilly and Companya

 

 

Cholera

10/31/1917

06/07/1979

Diphtheria & tetanus toxoids

09/09/1970

06/07/1979

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Diphtheria & tetanus toxoids, and pertussis vaccine adsorbed

09/09/1970

12/02/1985

DT, adsorbed

09/09/1970

06/07/1979

Influenza

11/09/1945

04/11/1977

Mumps vaccine

01/27/1950

04/11/1977

Pertussis vaccine

03/31/1915

03/07/1978

Rabies vaccine

06/07/1915

08/11/1982

Streptococcus vaccine

04/17/1952

10/27/1988

Tetanus toxoid

12/10/1935

06/07/1979

Tetanus toxoid, adsorbed

09/09/1970

06/07/1979

Tetanus & diphtheria toxoid adsorbed (for adult use)

09/09/1970

06/07/1979

Typhoid

02/04/1954

11/13/1978

Typhus

03/11/1941

06/07/1979

Evans Medical Ltd.c

 

 

Influenza

08/12/1988

 

Glaxo Operations, U.K. Ltd.a

 

 

BCG vaccine

01/24/1963

07/17/1990

Lederle Laboratories,d

 

 

American Cyanamid Company

 

 

Cholera

12/26/1941

 

Diphtheria & tetanus toxoids and acellular pertussis, adsorbed

12/17/1991

 

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

07/24/1970

 

DT, adsorbed

07/29/1970

 

Haemophilus influenzae type b polysaccharide vaccine

12/20/1985

 

Influenza

12/07/1945

 

Measles virus, live

05/03/1966

05/21/1980

Mumps vaccine

06/22/1950

05/24/1978

Pertussis vaccine

01/19/1914

05/29/1980

Pneumococcal vaccine, polyvalent

08/15/1979

 

Polio virus, live, oral trivalent

06/25/1963

 

Polio virus, oral, type 1

03/27/1962

 

Polio virus, oral, type 2

03/27/1962

 

Polio virus, oral, type 3

03/27/1962

 

Rocky mountain spotted fever

04/13/1942

06/11/1979

Small pox

03/01/1937

05/24/1978

Tetanus toxoid

06/15/1935

 

Tetanus toxoid, adsorbed

07/29/1970

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Tetanus & Diphtheria toxoids adsorbed (for adult use)

07/29/1970

 

Typhus

05/24/1967

11/20/1980

Massachusetts Public Health Biologic Laboratories

 

 

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

07/27/1970

 

Diphtheria toxoid

07/07/1932

05/19/1980

DT, adsorbed

07/27/1970

 

Small pox

03/20/1917

12/22/1976

Tetanus toxoid

05/16/1949

10/11/1989

Tetanus toxoid, adsorbed

07/29/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

07/27/1970

 

Typhoid

03/20/1917

10/26/1988

Merck and Company

 

 

Cholera

05/04/1952

01/31/1986

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

08/31/1970

01/31/1986

Haemophilus influenzae type b conjugate (meningococcal protein conjugate)

2/20/1989

 

Hepatitis B vaccine

11/16/1981

 

Hepatitis B recombinant

07/23/1986

 

Influenza

11/30/1945

 

Measles, live and small pox

11/17/1967

05/12/1987

Measles virus, live

03/21/1963

 

Measles and mumps virus, live

07/18/1973

 

Measles and rubella virus, live

04/22/1971

 

Measles, mumps, rubella, live

04/22/1971

 

Meningococcal polysaccharide A

07/11/1975

 

Meningococcal polysaccharide C

04/02/1974

 

Meningococcal polysaccharide A&C

10/06/1975

 

Meningococcal polysaccharide A. C, Y, W135 combined

12/14/1982

 

Mumps virus, live

12/28/1967

 

Pneumococcal

11/21/1977

 

Poliomyelitis, inactivated monkey kidney cell

04/12/1955

07/29/1980

Rubella virus, live

06/09/1969

 

Rubella and mumps, live

08/30/1970

 

Small pox

09/21/1965

07/29/1980

Tetanus toxoid

12/11/1933

01/31/1986

Tetanus toxoid, adsorbed

08/31/1970

01/31/1986

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Tetanus & diphtheria toxoids adsorbed (for adult use)

08/31/1970

01/31/1986

Typhoid

04/25/1963

01/31/1986

Typhus

12/24/1941

07/29/1980

Merrell-National Laboratories, Division of Richardson Merrella

 

 

Cholera

02/27/1942

03/25/1976

DTP

10/15/1970

01/03/1978

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

05/16/1949

01/03/1978

Diphtheria toxoid

09/28/1929

01/03/1978

Influenza

09/16/1947

01/03/1978

Meningococcal polysaccharide group A

09/19/1975

01/03/1978

Meningococcal polysaccharide group C

07/11/1975

01/03/1978

Meningococcal polysaccharide vaccine, groups A and C, combined

09/13/1976

01/03/1978

Pertussis vaccine

11/16/1926

01/03/1978

Small pox

03/05/1937

01/03/1978

Tetanus toxoid

05/25/1934

01/03/1978

Tetanus toxoid, adsorbed

10/15/1970

01/03/1978

Tetanus and diphtheria toxoids adsorbed (for adult use)

03/07/1955

01/03/1978

Yellow fever

05/22/1953

01/03/1978

Michigan Department of Public Health

 

 

Anthrax

11/04/1970

 

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

08/27/1970

 

DT, adsorbed

08/27/1970

 

Pertussis vaccine

11/22/1935

02/03/1977

Pertussis vaccine, adsorbed

10/12/1967

 

Rabies vaccine, adsorbed

03/18/1988

 

Smallpox

03/03/1937

06/25/1985

Tetanus toxoid, adsorbed

08/27/1970

 

Typhoid

07/26/1926

06/25/1985

Miles Inc.e

 

 

Cholera

10/03/1968

10/30/1970

Diphtheria and tetanus toxoids

06/01/1951

10/30/1970

DTP

05/04/1949

10/30/1970

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

05/04/1949

10/30/1970

Diphtheria toxoid

02/01/1928

10/30/1970

DT, adsorbed

05/04/1949

10/30/1970

DP, adsorbed

05/04/1949

10/30/1970

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Pertussis vaccine

08/03/1914

10/30/1970

Pertussis vaccine, adsorbed

05/03/1948

10/30/1970

Plague

05/14/1942

 

Poliomyelitis, inactivated monkey kidney cell

04/12/1955

12/28/1978

Small pox

08/21/1903

06/11/1973

Tetanus toxoid

09/25/1940

11/01/1979

Tetanus toxoid, adsorbed

05/04/1949

10/30/1970

Tetanus & diphtheria toxoids adsorbed (for adult use)

11/16/1956

10/30/1970

Typhoid

03/06/1916

10/30/1970

Organon Teknika Corporatione

 

 

BCG vaccine

06/21/1989

 

Parke Davis, Division of Warner Lambert Companya

 

 

Adenovirus

09/23/1957

07/29/1980

Adenovirus and influenza, combined aluminium phosphate adsorbed

09/22/1959

07/29/1980

Diphtheria and tetanus toxoids

07/29/1952

10/14/1981

DTP

07/29/1952

10/14/1981

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

07/08/1952

10/14/1981

Diphtheria toxoid

08/17/1927

10/14/1981

DT, adsorbed

07/08/1952

10/14/1981

DTP adsorbed, poliomyelitis

12/20/1963

10/14/1981

DTP, poliomyelitis adsorbed

03/25/1959

10/14/1981

Influenza

11/26/1945

 

Pertussis

04/16/1952

10/14/1981

Pertussis vaccine, adsorbed

02/20/1952

10/14/1981

Poliomyelitis, adsorbed

10/04/1960

07/29/1980

Poliomyelitis, inactivated monkey kidney cell

04/12/1955

07/29/1980

Rabies vaccine

08/05/1942

03/21/1973

Tetanus toxoid

05/04/1940

10/14/1981

Tetanus toxoid, adsorbed

07/08/1952

10/14/1981

Typhoid

03/24/1916

02/24/1959

Typhus

03/25/1942

08/05/1947

Pasteur Merieux Vaccins et Serums, S.A.b

 

 

Poliomyelitis, inactivated monkey kidney cell

12/21/1990

 

Rabies vaccine

06/09/1980

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Pfizer Ltd.a

 

 

Poliovirus, live, oral trivalent

10/28/1966

06/17/1979

Poliovirus, oral type 1

08/17/1961

06/12/1979

Poliovirus, oral type 2

10/06/1961

06/12/1979

Poliovirus, oral type 3

03/27/1962

06/12/1979

Praxis Biologics, Incorporatedd

 

 

Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)

12/21/1988

 

Haemophilus b polysaccharide vaccine

04/12/1985

 

Research Foundation for Microbial Diseases, Osaka University

 

 

Acellular pertussis vaccine concentrate

08/20/1992

 

Japanese encephalitis virus vaccine inactivated

12/10/1992

 

SCLAVO s.p.a.f

 

 

Cholera

08/19/1976

 

Diphtheria and tetanus toxoids and pertussis vaccine adsorbed

03/31/1978

 

Diphtheria toxoid

01/04/1963

 

DT, adsorbed

03/31/1978

 

Tetanus toxoid

01/04/1963

 

Tetanus toxoid, adsorbed

08/05/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

02/16/1979

 

SmithKline Beechame

 

 

Hepatitis B, recombinant

08/28/1989

 

Rubella virus, live

03/12/1970

10/05/1982

Swiss Serum Institute

 

 

Tetanus toxoid, adsorbed

12/11/1970

 

Typhoid vaccine, oral, Ty21a

12/15/1989

 

Takeda Chemical Industries, Ltd.,

 

 

Acellular pertussis vaccine concentrate (for further manufacturing)

12/17/1991

 

Texas Department of Health Resources

 

 

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

07/27/1970

02/06/1979

Diphtheria toxoid

01/06/1963

02/06/1979

DT, adsorbed

07/27/1970

02/06/1979

Pertussis

12/27/1954

02/06/1979

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.

Company and Vaccine or Product

Date of License

Date of Revocation

Tetanus toxoid

09/22/1959

02/06/1979

Tetanus & diphtheria toxoids adsorbed (for adult use)

07/27/1970

02/06/1979

Typhoid

07/11/1950

02/06/1979

University of Illinoisa

 

 

BCG vaccine

07/07/1950

05/29/1987

Wellcomed

 

 

Rubella virus, live

03/01/1977

 

Wyeth Laboratories

 

 

Adenovirus, live, oral, type 4

07/01/1980

 

Adenovirus, live, oral, type 7

07/01/1980

 

Cholera

07/16/1952

 

Diphtheria & tetanus toxoids and pertussis vaccine adsorbed

09/11/1970

 

Diphtheria toxoid

05/19/1944

05/19/1987

DT, adsorbed

09/11/1970

 

Influenza

12/13/1961

 

Pertussis vaccine

07/16/1952

05/19/1987

Rabies vaccine

08/11/1982

08/07/1986

Smallpox

05/19/1944

 

Tetanus toxoid

05/19/1944

 

Tetanus toxoid, adsorbed

09/11/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

09/11/1970

 

Typhoid

07/16/1952

 

a Company no longer produces any vaccines.

b Connaught Laboratories, Inc., (U.S.) and Connaught Laboratories, Ltd (Canada), are subsidiaries of Pasteur-Mérieux Sérums et Vaccins (France).

c Evans-Medical is a division of Medeva International, plc (United Kingdom); Medeva International plc acquired the vaccine business from Wellcome in 1991.

d Lederle Laboratories acquired Praxis Biologics in 1989. Lederle-Praxis Biologicals is now a business unit of American Cyanamid.

e Company produces one vaccine only for U.S. market.

f Sclavo spa is now owned by Ciba-Geigy (Switzerland) and Chiron (U.S.).

SOURCE: Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland.

Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
This page in the original is blank.
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 196
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 197
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 198
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 199
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 200
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 201
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 202
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 203
Suggested Citation: "Appendix H: Historical Record of Vaccine Product License Holders in the United States." Institute of Medicine. 1993. The Children's Vaccine Initiative: Achieving the Vision. Washington, DC: The National Academies Press. doi: 10.17226/2224.
Page 204
Next Chapter: Appendix I: Working Group Participants
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.